Table 5 Median and IQR of primary and secondary clinical outcomes at baseline (T0), post-treatment (T1) and follow-up (T2). + Friedman test, p < 0.05; * Wilcoxon signed-rank test, p < 0.025 (Bonferroni corrected)
Baseline (T0) Median (IQR) | Post-treatment (T1) Median (IQR) | Follow-up (T2) Median (IQR) | Friedman test | Wilcoxon signed-rank test | ||
|---|---|---|---|---|---|---|
p-value | p-value T0 to T1 | p-value T0 to T2 | ||||
FMA-UE | 42.0 (24.75 to 53.00) | 44.5 (26.25 to 54.75) | 45.5 (27.0 to 57.0) | 0.007+ | 0.131 | 0.035 |
AROM (in °) | ||||||
Shoulder flexion | 105.0 (63.8 to 118.8) | 117.5 (71.3 to 133.8) | 117.5 (77.5 to 131.3) | 0.010+ | 0.065 | 0.007* |
Elbow extension | −8.5 (−10.0 to −1.3) | −7.5 (−10.0 to 0.0) | −5.0 (−10 to 0) | 0.420 | ||
Wrist extension | 35.0 (6.3 to 55.0) | 37.5 (8.8 to 55.0) | 45.0 (22.5 to 60.0) | 0.095 | ||
Forearm supination | 62.5 (5.0 to 78.8) | 57.5 (12.5 to 83.8) | 67.5 (12.5 to 80.0) | 0.131 | ||
Forearm pronation | 62.5 (0.0 to 83.8) | 87.5 (56.3 to 90.0) | 87.5 (57.5 to 90.0) | 0.032+ | 0.027 | 0.128 |
mMRCS | ||||||
Shoulder flexion | 3 (3.0 to 3.8) | 3.5 (3.0 to 4.0) | 3.5 (3.0 to 4.0) | 0.156 | ||
Elbow extension | 2.5 (2.0 to 3.0) | 3 (2.3 to 3.8) | 3 (2.3 to 4.0) | 0.074 | ||
Wrist extension | 3 (1.5 to 4.0) | 3 (2.3 to 4.0) | 3.5 (2.3 to 4.0) | 0.174 | ||
Forearm supination | 3 (1.3 to 4.0) | 3.5 (1.5 to 4.0) | 3.5 (1.5 to 4.0) | 0.424 | ||
Forearm pronation | 3 (0.5 to 4.0) | 3.5 (2.3 to 4.0) | 3.5 (3.0 to 4.0) | 0.350 | ||
FIM | 121.5 (106.3 to 125.3) | 121 (105 to 123) | 121.5 (108.8 to 123.8) | 1 | ||
VAS | ||||||
Shoulder flexion | 0 (0 to 6) | 1 (0 to 2) | 0 (0 to 1.75) | 0.368 | ||
Elbow extension | 0 (0 to 4) | 0 (0 to 0) | 0 (0 to 0) | 0.146 | ||
Wrist extension | 0 (0 to 4) | 0 (0 to 0) | 0 (0 to 0) | 0.0498+ | 0.103 | 0.103 |
Forearm supination | 0 (0 to 0) | 0 (0 to 0) | 0 (0 to 0) | 0.135 | ||
Forearm pronation | 0 (0 to 0) | 0 (0 to 0) | 0 (0 to 0) | 0.368 | ||